Search

New research looks at how a series of mutations in normal blood cells can lead to them becoming cancerous and how these mutations accumulate as cancer progresses.

… Wednesday, October 28, 2020 Summary The biggest study ever to examine the genetic causes of leukemia at the level of individual cells reveals how a series of mutations in normal blood cells can lead to them eventually becoming cancerous. When Memorial Sloan Kettering postdoctoral fellows Linde Miles

Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over a month away.

… Monday, June 5, 2023 Kieran Healy was feeling worse by the day. A new father at 43 years old, he was bone-tired and losing weight. He had night sweats and a strange lump in his belly. His local hospital in Manhattan ordered an ultrasound and a CT (computed tomography) scan — but they were scheduled over

Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to mitigate modifiable risk.

… Wednesday, August 23, 2017 Data from a recent study on women enrolled in Memorial Sloan Kettering Cancer Center’s high-risk breast cancer surveillance program highlights that a “substantial number” would benefit from interventions to further reduce risk, including education on modifiable lifestyle factors

Researchers at Memorial Sloan Kettering Cancer Center (MSK), have published the first systemic review of the association between industry payments and physician prescribing in order to determine whether evidence is sufficient to conclude that payments cause physicians to change their prescribing practices across a broad range of  medical specialties and drug types.

… Monday, November 23, 2020 Researchers at Memorial Sloan Kettering Cancer Center (MSK), led by Aaron Mitchell, MD, MPH, a medical oncologist and health services researcher in the  Department of Epidemiology and Biostatistics , have published the first systemic review of the association between industry

Wondering how cryo-electron microscopy will impact medicine? Hear it from the source.

… Friday, September 9, 2016 Summary Memorial Sloan Kettering recently acquired a powerful new microscope that promises to greatly enhance scientists’ ability to understand the structure and function of biological molecules — including those that malfunction in cancer. In biology, structure and function

A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant.

… Friday, August 14, 2020 A single surviving myeloma cell can seed accelerated relapse, and more than 20 percent of nonsynonymous mutations at relapse may be induced by exposure to chemotherapy such as platinum and high-dose melphalan after autologous stem cell transplant, according to our research, published

Learn why an MSK patient is supporting the MSK mission with a bequest.

… Tuesday, November 7, 2023 Claire Theobald’s journey with breast cancer has taught her to cherish every small, beautiful moment of life. It has also inspired her to include Memorial Sloan Kettering Cancer Center (MSK) in her estate planning by making a bequest to MSK in her will. Her hope, she explains

Women with Stage III ovarian cancer when treated with a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, survived almost a year longer than those who received IV chemotherapy alone.

… Wednesday, January 4, 2006 According to a study published in the January 5 issue of the New England Journal of Medicine , women with Stage III ovarian cancer given a combination of intravenous (IV) and intra-abdominal chemotherapy, following the successful surgical removal of tumors, experienced a median

An MSK expert gives advice on how to talk to family and friends about a cancer diagnosis linked to HPV, which some people find particularly challenging.

… Tuesday, May 3, 2022 Talking about a cancer diagnosis can be tough. Talking with friends, family, and others about a cancer diagnosis linked to HPV can be particularly challenging for many people. Memorial Sloan Kettering Cancer Center (MSK) clinical social worker Victoria Lassen has counseled people

Un experto de MSK ofrece consejos sobre cómo hablar con familiares y amigos sobre un diagnóstico de cáncer relacionado con el VPH, algo que para algunas personas puede resultar especialmente difícil.

… Tuesday, May 3, 2022 Hablar sobre un diagnóstico de cáncer puede ser difícil. Hablar con amigos, familiares y otras personas sobre un diagnóstico de cáncer relacionado con el VPH puede resultar especialmente difícil para muchas personas. Victoria Lassen , trabajadora social clínica del Memorial Sloan